These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10574517)

  • 1. Biologic response to peripheral and central administration of recombinant human leptin in dogs.
    LeBel C; Bourdeau A; Lau D; Hunt P
    Obes Res; 1999 Nov; 7(6):577-85. PubMed ID: 10574517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
    Heymsfield SB; Greenberg AS; Fujioka K; Dixon RM; Kushner R; Hunt T; Lubina JA; Patane J; Self B; Hunt P; McCamish M
    JAMA; 1999 Oct; 282(16):1568-75. PubMed ID: 10546697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of human leptin in mice and rhesus monkeys.
    Ahrén B; Baldwin RM; Havel PJ
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1579-85. PubMed ID: 11126209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous lumbar intrathecal infusion of leptin in rats on weight regulation.
    Yaksh TL; Scott B; LeBel CL
    Neuroscience; 2002; 110(4):703-10. PubMed ID: 11934477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related steady states of fat loss in long-term leptin-treated ob/ob mice: leptin resistance or desensitization versus counterregulatory signaling.
    Eiden S; Simon E; Schmidt I
    J Comp Physiol B; 2005 Oct; 175(7):487-97. PubMed ID: 16088390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.
    Chan JL; Wong SL; Mantzoros CS
    Clin Pharmacokinet; 2008; 47(11):753-64. PubMed ID: 18840030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice.
    Lalonde J; Samson P; Poulin S; Deshaies Y; Richard D
    Physiol Behav; 2004 Jan; 80(4):415-20. PubMed ID: 14741225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
    Priestman DA; van der Spoel AC; Butters TD; Dwek RA; Platt FM
    Diabetes Obes Metab; 2008 Feb; 10(2):159-66. PubMed ID: 18190430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice.
    Pelleymounter MA; Cullen MJ; Healy D; Hecht R; Winters D; McCaleb M
    Am J Physiol; 1998 Oct; 275(4):R950-9. PubMed ID: 9756522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
    Larsen PJ; Vrang N; Petersen PC; Kristensen P
    Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
    Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
    Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of leptin administration in non-obese human subjects.
    Mackintosh RM; Hirsch J
    Obes Res; 2001 Aug; 9(8):462-9. PubMed ID: 11500526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmenting leptin circadian rhythm following a weight reduction in diet-induced obese rats: short- and long-term effects.
    Buison A; Pellizzon M; Ordiz F; Jen KL
    Metabolism; 2004 Jun; 53(6):782-9. PubMed ID: 15164329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
    Zelissen PM; Stenlof K; Lean ME; Fogteloo J; Keulen ET; Wilding J; Finer N; Rössner S; Lawrence E; Fletcher C; McCamish M;
    Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats.
    Chen Y; Heiman ML
    Regul Pept; 2000 Aug; 92(1-3):113-9. PubMed ID: 11024573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
    Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the obese gene product on body weight regulation in ob/ob mice.
    Pelleymounter MA; Cullen MJ; Baker MB; Hecht R; Winters D; Boone T; Collins F
    Science; 1995 Jul; 269(5223):540-3. PubMed ID: 7624776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic activity of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for weight loss in obese dogs.
    Wren JA; King VL; Campbell SL; Hickman MA
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():33-42. PubMed ID: 17567513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding.
    Morley JE; Alshaher MM; Farr SA; Flood JF; Kumar VB
    Peptides; 1999; 20(5):595-600. PubMed ID: 10465511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.